Triplet‐drug chemotherapy combined with anti‐EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysis

The meta-analysis aimed to assess the clinical efficacy of chemotherapeutic triplet‐drug regimen combined with anti‐EGFR antibody in patients with initially unresectable metastatic colorectal cancer (mCRC). A systematic literature search was performed in PubMed Publisher. Studies evaluating FOLFOXIR...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Muyou, Li, Huifen, Dong, Wenjing, Li, Yuhong, Jiang, Ting, Lv, Yanhua, Zeng, Jianxiong, Jiang, Xiaomei, Yin, Zhaofeng, Xiao, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656984/
https://www.ncbi.nlm.nih.gov/pubmed/37978547
http://dx.doi.org/10.1186/s12957-023-03256-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656984/
https://www.ncbi.nlm.nih.gov/pubmed/37978547
http://dx.doi.org/10.1186/s12957-023-03256-7

Ejemplares similares